Source comparison
MOTS-c 60s Age Specific Protocol: Dosing & Timing Comparison
Per-Dose Amount 10–15mg weekly 2.5–5mg every 3–4 days Reduced mitochondrial processing capacity in older populations requires lower single doses to avoid overwhelming repair bandwidth Frequency over quantity is the critical shift. Older mitochondria respond be
This comparison does not assign a generated winner or score.
- Per-Dose Amount
- 10–15mg weekly
- 2.5–5mg every 3–4 days
- Reduced mitochondrial processing capacity in older populations requires lower single doses to avoid overwhelming repair bandwidth
- Frequency over quantity is the critical shift. Older mitochondria respond better to sustained low-level activation than high-dose pulses
- Administration Timing
- Flexible (fasted or fed state)
- Fasted state only (minimum 8-hour overnight fast)
- Insulin sensitivity declines ~1% per year after age 50. Fasted dosing standardizes baseline insulin levels and reduces inter-dose variability
- Non-negotiable for consistent results in older cohorts. Fed-state dosing introduces 25–40% variability in AMPK activation
- Reconstitution Stability Window
- 28 days at 2–8°C
- 21 days at 2–8°C (rear refrigerator placement)
- Household refrigerators used by older adults experience more frequent temperature fluctuations. Shorter window prevents degraded peptide administration
- The stability reduction isn't age physiology. It's storage environment realism for this demographic
- Injection Site Rotation
- Standard subcutaneous sites
- Rotate between abdomen and anterior thigh (avoid arms if reduced muscle mass)
- Subcutaneous absorption depends on adequate adipose tissue thickness. Older adults with sarcopenia may have insufficient tissue in upper arms
- Arms are viable in younger populations but unreliable in individuals over 60 with reduced muscle mass
- Monitoring Threshold
- Subjective energy/recovery assessment
- Weekly fasting glucose and HbA1c at 8-week intervals
- MOTS-c improves insulin sensitivity. Older populations with pre-existing metabolic variability need quantitative monitoring to detect hypoglycemia risk
- Subjective assessment alone misses metabolic shifts that matter more in older individuals with baseline insulin resistance